IFNGR1 and neoplasm: Blunted effector functions of IFNGR1-deficient CAR T-cells correlated with reduced induction of immunogenic cell death markers on tumor cells (Figure S7E), decreased tumor antigen uptake by intratumoral DCs (Figure S7F–G), and reduced tumor antigen acquisition by lymph node-resident CD8α+ cDC1 (Figure S7H); tumor antigen uptake by LN cDC2 was low and unaffected (Figure S7I).